BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30549073)

  • 21. The effect of pirfenidone on rat chronic prostatitis/chronic pelvic pain syndrome and its mechanisms.
    Peng X; Guo H; Chen J; Wang J; Huang J
    Prostate; 2020 Sep; 80(12):917-925. PubMed ID: 32569423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in erectile organ structure and function in a rat model of chronic prostatitis/chronic pelvic pain syndrome.
    Wang XJ; Xia LL; Xu TY; Zhang XH; Zhu ZW; Zhang MG; Liu Y; Xu C; Zhong S; Shen ZJ
    Andrologia; 2016 Apr; 48(3):243-51. PubMed ID: 25990367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Hiramatsu I; Tsujimura A; Soejima M; Yoshiyama A; Nagashima Y; Ishikawa K; Uesaka Y; Nozaki T; Ogishima T; Shirai M; Mitsuhashi I; Sugimura S; Mizuno T; Noto K; Shigeta Y; Takasu J; Honda S; Iwata S; Horie S
    Int J Urol; 2020 Jan; 27(1):53-57. PubMed ID: 31587411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome.
    Motrich RD; Breser ML; Sánchez LR; Godoy GJ; Prinz I; Rivero VE
    Pain; 2016 Mar; 157(3):585-597. PubMed ID: 26882345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
    Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
    Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of an animal model of prostate inflammation-induced chronic pelvic pain: evaluating from inflammation of the prostate to pain behavioral modifications.
    Zeng F; Chen H; Yang J; Wang L; Cui Y; Guan X; Wang Z; Niu J; Zu X; Qi L; Zhang X; Tang Z; Liu L
    PLoS One; 2014; 9(5):e96824. PubMed ID: 24823660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.
    Zhang M; Lin D; Luo C; Wei P; Cui K; Chen Z
    Oxid Med Cell Longev; 2022; 2022():1247806. PubMed ID: 35154561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder function in 17β-estradiol-induced nonbacterial prostatitis model in Wistar rat.
    Matsumoto S; Kawai Y; Oka M; Oyama T; Hashizume K; Wada N; Hori J; Tamaki G; Kita M; Iwata T; Kakizaki H
    Int Urol Nephrol; 2013 Jun; 45(3):749-54. PubMed ID: 23616059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis.
    Quick ML; Mukherjee S; Rudick CN; Done JD; Schaeffer AJ; Thumbikat P
    Am J Physiol Regul Integr Comp Physiol; 2012 Sep; 303(6):R580-9. PubMed ID: 22814670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
    BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation.
    Peng X; Guo H; Yuan J; Chen Y; Xia Y; Wang L; Wang Y; Huang Y; Xie H; Wang Y; Chen F
    Stem Cell Res Ther; 2021 Mar; 12(1):198. PubMed ID: 33743834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial Effects of Inflammatory Cytokine-Targeting Aptamers in an Animal Model of Chronic Prostatitis.
    Ho DR; Chang PJ; Lin WY; Huang YC; Lin JH; Huang KT; Chan WN; Chen CS
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine.
    Liu YF; Xie WJ; Xi P; Zhang ZC; Chen R; Fu SQ; Lei KY; Liu J; Cheng XF; Nie YC; Yang XR; Ma M; Sun T; Gong BB
    Phytomedicine; 2024 Jan; 123():155249. PubMed ID: 38056144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
    Murphy SF; Schaeffer AJ; Done J; Wong L; Bell-Cohn A; Roman K; Cashy J; Ohlhausen M; Thumbikat P
    PLoS One; 2015; 10(5):e0125623. PubMed ID: 25933188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome.
    Roman K; Done JD; Schaeffer AJ; Murphy SF; Thumbikat P
    Pain; 2014 Jul; 155(7):1328-1338. PubMed ID: 24726923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of melittin on a rat model of chronic prostatitis induced by Complete Freund's Adjuvant.
    Lin L; Zhu BP; Cai L
    Biomed Pharmacother; 2017 Jun; 90():921-927. PubMed ID: 28441718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.
    Lin D; Zhang M; Luo C; Wei P; Cui K; Chen Z
    J Immunol Res; 2022; 2022():6833867. PubMed ID: 35755168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.
    Zhang ZY; Schluesener HJ
    Prostate; 2012 Jan; 72(1):90-9. PubMed ID: 21538420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA; Mosli HA; Farsi H; Alsayyad A; Tayib A; Sait M; Abdelsalam A
    Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.